January 19, 2025 · Form 4 insider transaction
Collard Craig A bought 13,797 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of common stock.; Includes 10,683 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2024.